• Explore /
  • Poster
  • / Regorafenib and nivolumab combination therapy for advanced and metastatic solid tumors: Phase I clinical trial (EPOC1603).

Regorafenib and nivolumab combination therapy for advanced and metastatic solid tumors: Phase I clinical trial (EPOC1603).

Abstract Poster

Authors

null

Shota Fukuoka

Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan

Shota Fukuoka , Hiroki Hara , Satoshi Shimizu , Hideaki Takahashi , Masafumi Ikeda , Hitomi Tamura , Yuichi Mikamoto , Miki Fukutani , Masashi Wakabayashi , Shogo Nomura , Akihiro Sato , Kohei Shitara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Immune Checkpoint Inhibitors

Citation

J Clin Oncol 36, 2018 (suppl; abstr TPS3124)

DOI

10.1200/JCO.2018.36.15_suppl.TPS3124

Abstract #

TPS3124

Poster Bd #

326b

Abstract Disclosures

Similar Posters

First Author: Jessica Dreger McDermott

First Author: Vivek Subbiah

First Author: Julie Marie Collins

First Author: Laura Quan Man Chow